Nivolumab Injection 40MG/100MG is an important oncology immunotherapy medicine used in the treatment of several cancers. Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical exporter and drop shipper, supports international pharmaceutical supply requirements for healthcare institutions, distributors and eligible buyers in markets including the USA, UK, UAE and South Africa, subject to applicable import and regulatory requirements.
Nivolumab is a PD-1 immune checkpoint inhibitor. It works by blocking PD-1, helping the immune system recognize and attack certain cancer cells.
Nivolumab Injection 40MG/100MG Export from India
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical sourcing and export support for Nivolumab Injection 40MG and 100MG from India.
Common IV presentations include:
Nivolumab 40MG/4ML Injection
Nivolumab 100MG/10ML Injection
Single-dose vial presentations
Intravenous administration under professional medical supervision
The FDA lists 40MG/4ML and 100MG/10ML among approved intravenous nivolumab presentations.
Nivolumab Injection Uses
Nivolumab may be prescribed alone or in combination with other medicines for several approved cancer indications, depending on the patient's diagnosis and applicable regulatory labeling.
These include certain cases of:
Melanoma
Non-small cell lung cancer
Renal cell carcinoma
Classical Hodgkin lymphoma
Urothelial carcinoma
Head and neck cancer
Colorectal cancer with specific biomarkers
Hepatocellular carcinoma
Esophageal and gastric cancers
Malignant pleural mesothelioma
Approved uses and treatment combinations vary by country and patient characteristics.
Nivolumab Benefits
As an immunotherapy medicine, nivolumab can:
Help activate the immune system against cancer cells.
Block the PD-1 immune checkpoint pathway.
Be used as monotherapy or as part of combination cancer treatment.
Support treatment strategies for multiple approved solid tumors and blood cancers.
Treatment decisions should always be made by a qualified oncologist based on the patient's cancer type, stage, biomarkers and treatment history.
Nivolumab Injection Supply to USA, UK, UAE & South Africa
🇺🇸 USA
Cordium Pharmaceuticals Pvt Ltd can support pharmaceutical sourcing and export enquiries for Nivolumab Injection 40MG/100MG intended for eligible healthcare and pharmaceutical buyers in the USA. Importation and use must comply with applicable U.S. FDA requirements.
🇬🇧 UK
Nivolumab supply enquiries can be supported for the UK market, including pharmaceutical distributors and healthcare-sector buyers, subject to UK medicines and import regulations.
🇦🇪 UAE
Cordium Pharma supports export enquiries for Nivolumab Injection to the UAE, including Dubai, Abu Dhabi and Sharjah, subject to applicable UAE registration, import and customs requirements.
🇿🇦 South Africa
Nivolumab Injection sourcing and export enquiries can be handled for South Africa, subject to local pharmaceutical import and regulatory requirements.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter and drop shipper
Support for international pharmaceutical sourcing
Nivolumab Injection 40MG/100MG availability enquiries
Documentation and export coordination support
Supply assistance for eligible distributors and healthcare buyers
International shipping coordination
Focus on compliant pharmaceutical trade and professional buyers
Frequently Asked Questions
1. What is Nivolumab Injection 40MG/100MG?
Nivolumab is a prescription immunotherapy medicine and PD-1 immune checkpoint inhibitor used for several cancer indications.
2. What are the strengths of Nivolumab Injection?
Common intravenous presentations include 40MG/4ML and 100MG/10ML single-dose vials.
3. Is Nivolumab chemotherapy?
No. Nivolumab is an immunotherapy medicine rather than conventional cytotoxic chemotherapy.
4. How is Nivolumab administered?
Nivolumab intravenous formulations are administered by qualified healthcare professionals through IV infusion.
5. Can Cordium Pharmaceuticals export Nivolumab from India?
Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical export and sourcing enquiries, subject to product availability, destination-country regulations and required documentation.
6. Is Nivolumab available for the USA, UK, UAE and South Africa?
Supply enquiries can be supported for these markets, but importation, registration, licensing and prescription requirements vary by country.
7. Does Nivolumab have side effects?
Yes. Nivolumab can cause adverse reactions, including immune-mediated reactions affecting organs such as the lungs, liver, intestines, kidneys, skin and endocrine system.
Nivolumab is a PD-1 immune checkpoint inhibitor. It works by blocking PD-1, helping the immune system recognize and attack certain cancer cells.
Nivolumab Injection 40MG/100MG Export from India
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical sourcing and export support for Nivolumab Injection 40MG and 100MG from India.
Common IV presentations include:
Nivolumab 40MG/4ML Injection
Nivolumab 100MG/10ML Injection
Single-dose vial presentations
Intravenous administration under professional medical supervision
The FDA lists 40MG/4ML and 100MG/10ML among approved intravenous nivolumab presentations.
Nivolumab Injection Uses
Nivolumab may be prescribed alone or in combination with other medicines for several approved cancer indications, depending on the patient's diagnosis and applicable regulatory labeling.
These include certain cases of:
Melanoma
Non-small cell lung cancer
Renal cell carcinoma
Classical Hodgkin lymphoma
Urothelial carcinoma
Head and neck cancer
Colorectal cancer with specific biomarkers
Hepatocellular carcinoma
Esophageal and gastric cancers
Malignant pleural mesothelioma
Approved uses and treatment combinations vary by country and patient characteristics.
Nivolumab Benefits
As an immunotherapy medicine, nivolumab can:
Help activate the immune system against cancer cells.
Block the PD-1 immune checkpoint pathway.
Be used as monotherapy or as part of combination cancer treatment.
Support treatment strategies for multiple approved solid tumors and blood cancers.
Treatment decisions should always be made by a qualified oncologist based on the patient's cancer type, stage, biomarkers and treatment history.
Nivolumab Injection Supply to USA, UK, UAE & South Africa
🇺🇸 USA
Cordium Pharmaceuticals Pvt Ltd can support pharmaceutical sourcing and export enquiries for Nivolumab Injection 40MG/100MG intended for eligible healthcare and pharmaceutical buyers in the USA. Importation and use must comply with applicable U.S. FDA requirements.
🇬🇧 UK
Nivolumab supply enquiries can be supported for the UK market, including pharmaceutical distributors and healthcare-sector buyers, subject to UK medicines and import regulations.
🇦🇪 UAE
Cordium Pharma supports export enquiries for Nivolumab Injection to the UAE, including Dubai, Abu Dhabi and Sharjah, subject to applicable UAE registration, import and customs requirements.
🇿🇦 South Africa
Nivolumab Injection sourcing and export enquiries can be handled for South Africa, subject to local pharmaceutical import and regulatory requirements.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter and drop shipper
Support for international pharmaceutical sourcing
Nivolumab Injection 40MG/100MG availability enquiries
Documentation and export coordination support
Supply assistance for eligible distributors and healthcare buyers
International shipping coordination
Focus on compliant pharmaceutical trade and professional buyers
Frequently Asked Questions
1. What is Nivolumab Injection 40MG/100MG?
Nivolumab is a prescription immunotherapy medicine and PD-1 immune checkpoint inhibitor used for several cancer indications.
2. What are the strengths of Nivolumab Injection?
Common intravenous presentations include 40MG/4ML and 100MG/10ML single-dose vials.
3. Is Nivolumab chemotherapy?
No. Nivolumab is an immunotherapy medicine rather than conventional cytotoxic chemotherapy.
4. How is Nivolumab administered?
Nivolumab intravenous formulations are administered by qualified healthcare professionals through IV infusion.
5. Can Cordium Pharmaceuticals export Nivolumab from India?
Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical export and sourcing enquiries, subject to product availability, destination-country regulations and required documentation.
6. Is Nivolumab available for the USA, UK, UAE and South Africa?
Supply enquiries can be supported for these markets, but importation, registration, licensing and prescription requirements vary by country.
7. Does Nivolumab have side effects?
Yes. Nivolumab can cause adverse reactions, including immune-mediated reactions affecting organs such as the lungs, liver, intestines, kidneys, skin and endocrine system.
Keywords
